Lito Sousa: Medicinal Product Arriving in Brazil - 13/09/2026 - Equilibrio E Saúde
7 Articles
7 Articles
Lito Sousa in video published on Friday (4) Reproduction A joint operation between the Federal Revenue and the National Agency for Health Surveillance (Anvisa) allowed the rapid release of the experimental drug intended for the treatment of the influencer Lito Sousa, diagnosed with Creutzfeldt-Jakob disease. Agility was necessary because the therapeutic potential of the substance decreases rapidly over the hours. On September 4, Anvisa authorize…
Federal Revenue and Anvisa anticipated procedures to release the medication a few minutes after their arrival in Brazil
Experimental substance ALN-6457, which presents therapeutic potential that decreases over time, was dispatched in minutes at Guarulhos International Airport
A joint operation of the Federal Revenue and the National Health Surveillance Agency (Anvisa) allowed the rapid release of the experimental drug ALN-6457, intended for the treatment of the influencer Lito Sousa, diagnosed with Creutzfeldt-Jakob disease. The charge arrived in Brazil on Saturday morning (12), at the São Paulo International Airport, in Guarulhos, from [...]
Remedy was imported through a request from Einstein Israeli Hospital after Lito was accepted into a compassionate use program
Influencer was diagnosed with Creutzfeldt-Jakob disease
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
